TMCnet News
Companion Diagnostics Market to Reach $6.5 Billion by 2022: Analysis by Technology, Indication, and End User - Research and MarketsThe "Companion Diagnostics Market by Technology, Indication, and End User - Global Forecast to 2022" report has been added to Research and Markets' offering. The global companion diagnostics market is projected to reach USD 6.51 billion by 2022 from USD 2.61 billion in 2017, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, and increasing collaborations and partnerships for companion diagnostics test development. However, uncertain reimbursement scenarios in different countries such as the U.S., the U.K., Japan, and Australia are expected to limit market growth. North America held the largest share of the global companion diagnostics market in 2016, while Asia-Pacific is expected to witness the highest growth during 2017 to 2022. Growing need for tailored therapeutics by the elderly population, increasing number of hospitals and diagnostic laboratories, and groing prevalence of life-threatening diseases are driving the growth of the companion diagnostics market in the Asia-Pacific region. Companies Mentioned
Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Companion Diagnostics Market, By Product & Service 7 Companion Diagnostics Market, By Technology 8 Companion Diagnostics Market, By Indication 9 Companion Diagnostics Market, By End User 10 Companion Diagnostics Market, By Region 11 Competitive Landscape 12 Company Profiles For more information about this report visit https://www.researchandmarkets.com/research/46m83w/companion
View source version on businesswire.com: http://www.businesswire.com/news/home/20170808005821/en/ |
